Insights and News Curated for Life Science Experts by Life Science Experts....

INSIGHTS HUB

As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...

In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...

How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...

San Diego, CA, November 13, 2024 (Globe Newswire) -- Zentalis Pharmaceuticals has appointed Julie Eastland as CEO, supported by Ingmar...

Marlborough, MA, November 15, 2024 (PRNewswire) -- Boston Scientific has acquired Axonics for $3.7 billion, expanding its Urology...

Boston, MA, October 30, 2024 (PRNewswire) -- Axonis Therapeutics raised $115 million in Series A funding to advance AXN-027 for...

Houston, TX, November 5, 2024 (PRNewswire) -- Celltex Therapeutics appointed Anita Perry as CEO following the retirement of Co-Founder...

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to...

Rockville, MD, November 6, 2024 (PRNewswire) -- I-Mab has named Dr. Sean Fu as its CEO to drive forward its cancer immunotherapy...

North Chicago, IL, October 28, 2024 (Reuters) -- AbbVie will acquire Aliada Therapeutics for $1.4 billion to gain access to an...

Los Angeles, CA, October 17, 2024 (Business Wire) -- Terray Therapeutics has successfully raised $120 million in Series B funding to...

Cambridge, UK, October 18, 2024 ( GlobeNewswire ) -- ViaNautis Bio has appointed Dr. Adi Hoess as its new Chief Executive Officer,...

Watertown, MA, October 22, 2024 (PRNewswire) -- AvenCell Therapeutics has secured $112 million in Series B funding to enhance its...

Palo Alto, CA, October 10, 2024 (Business Wire) -- Mike Alvarez has been appointed as the Chief Executive Officer of Glooko, Inc.,...

Boston, MA, October 21, 2024 (Business Wire) -- Seaport Therapeutics has raised $225 million in a Series B financing round led by...